Hearing: Antitrust Concerns and the FDA Approval Process

Subcommittee on Regulatory Reform, Commercial, and Antitrust Law (Committee on the Judiciary)

Thursday, July 27, 2017 (1:00 PM)

2141 RHOB
Washington, D.C.

Witnesses

Alden Abbott Esq.
Deputy Director and Senior Legal Fellow, The Heritage Foundaiton

Added 07/24/2017 at 05:48 PM
  • Witness Statement [PDF] Added 07/28/2017 at 10:30 AM
  • Witness Truth in Testimony [PDF] Added 08/09/2017 at 11:43 AM

Scott Gottlieb M.D.
Commissioner, Food & Drug Administration

Added 07/24/2017 at 05:48 PM
  • Witness Statement [PDF] Added 07/28/2017 at 10:30 AM

Aaron S. Kesselheim M.D., M.P.H.
Associate Professor of Medicine, Harvard Medical School

Added 07/24/2017 at 05:48 PM
  • Witness Statement [PDF] Added 07/28/2017 at 10:30 AM
  • Witness Biography [PDF] Added 08/09/2017 at 11:43 AM

Erika Lietzan Esq.
Associate Professor of Law, University of Missouri School of Law

Added 07/24/2017 at 05:48 PM
  • Witness Statement [PDF] Added 07/28/2017 at 10:30 AM
  • Witness Truth in Testimony [PDF] Added 08/09/2017 at 11:43 AM

Markus H. Meier
Acting Director, Bureau of Competition, Federal Trade Commission, Assistant Director, Health Care Division

Added 07/24/2017 at 05:48 PM
  • Witness Statement [PDF] Added 07/28/2017 at 10:30 AM

David S. Olson Esq.
Associate Professor of Law, Boston College of Law

Added 07/24/2017 at 05:48 PM
  • Witness Statement [PDF] Added 07/28/2017 at 10:30 AM
  • Witness Truth in Testimony [PDF] Added 08/09/2017 at 11:43 AM

Support Documents

  • Notice of Hearing [PDF] Added 07/20/2017 at 04:10 PM
  • Hearing: Witness List [PDF] Added 07/24/2017 at 05:40 PM

First Published: July 20, 2017 at 04:09 PM
Last Updated: August 9, 2017 at 11:43 AM